Study of Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in Unresectable Gastric Cancer

NCT02529878 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: S1/Paclitaxel chemotherapy plus Apatinib

Sponsor

The First Affiliated Hospital of Zhejiang Chinese Medical University

Collaborators

[object Object]